Stockreport

Passage Bio to Present at Guggenheim Healthcare Talks 6th Annual Biotechnology Conference

Passage Bio, Inc.  (PASG) 
PDF PHILADELPHIA, Jan. 31, 2024 (GLOBE NEWSWIRE) -- Passage Bio, Inc. (NASDAQ: PASG), a clinical-stage genetic medicines company focused on improving the lives of patients [Read more]